About Apyx Medical Corporation
https://www.apyxmedical.comApyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM).
CEO
Charles D. Goodwin II
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 13
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:3.34M
Value:$12.55M
ARCHON CAPITAL MANAGEMENT LLC
Shares:3.28M
Value:$12.34M
ROYCE & ASSOCIATES LP
Shares:2.47M
Value:$9.3M
Summary
Showing Top 3 of 59
About Apyx Medical Corporation
https://www.apyxmedical.comApyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM).
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $12.88M ▲ | $9.13M ▼ | $-1.98M ▲ | -15.41% ▲ | $-0.05 ▲ | $-332K ▲ |
| Q2-2025 | $11.37M ▲ | $9.66M ▲ | $-3.78M ▲ | -33.22% ▲ | $-0.09 ▲ | $-2.16M ▲ |
| Q1-2025 | $9.43M ▼ | $8.72M ▼ | $-4.15M ▲ | -44.01% ▼ | $-0.12 | $-2.61M ▲ |
| Q4-2024 | $14.22M ▲ | $12.01M ▲ | $-4.63M ▲ | -32.54% ▲ | $-0.12 ▲ | $-2.77M ▲ |
| Q3-2024 | $11.49M | $10.59M | $-4.7M | -40.94% | $-0.14 | $-3.09M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $25.14M ▼ | $57.37M ▼ | $51.28M ▲ | $5.85M ▼ |
| Q2-2025 | $29.3M ▼ | $58.19M ▼ | $50.73M ▲ | $7.25M ▼ |
| Q1-2025 | $31.01M ▼ | $60.16M ▼ | $49.52M ▼ | $10.51M ▼ |
| Q4-2024 | $31.74M ▲ | $64.84M ▲ | $50.51M ▲ | $14.21M ▲ |
| Q3-2024 | $28.01M | $60.72M | $49.52M | $11.04M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.98M ▲ | $-3.54M ▼ | $-519K ▼ | $45K ▲ | $-4.17M ▼ | $-4.05M ▼ |
| Q2-2025 | $-3.74M ▲ | $-1.23M ▼ | $-265K ▼ | $25K | $-1.71M ▼ | $-1.5M ▼ |
| Q1-2025 | $-4.15M ▲ | $-702K ▲ | $-55K ▲ | $25K ▼ | $-730K ▼ | $-757K ▲ |
| Q4-2024 | $-4.66M ▲ | $-2.94M ▲ | $-245K ▼ | $6.76M ▲ | $3.73M ▲ | $-3.18M ▲ |
| Q3-2024 | $-4.77M | $-4.44M | $-153K | $-5K | $-4.67M | $-4.59M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Advanced Energy | $20.00M ▲ | $0 ▼ | $10.00M ▲ | $10.00M ▲ |
 OEM | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 NonUS | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 UNITED STATES | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
CEO
Charles D. Goodwin II
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 13
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NANTAHALA CAPITAL MANAGEMENT, LLC
Shares:3.34M
Value:$12.55M
ARCHON CAPITAL MANAGEMENT LLC
Shares:3.28M
Value:$12.34M
ROYCE & ASSOCIATES LP
Shares:2.47M
Value:$9.3M
Summary
Showing Top 3 of 59